Sha'ar Mivnim

Overview

Sha'ar Mivnim is a venture capital firm dedicated to investing in early-stage life sciences companies in Israel. The firm focuses on startups with exceptional technology or proprietary advantages poised to capitalize on major market trends. Sha'ar Mivnim's target initial investment size ranges from $3 million to $7 million, with typical total investments of $7 million to $15 million over the lifespan of the investment. The firm believes that Israel presents an excellent source of life science technology investment opportunities, particularly in the field of medical devices. The Israeli life science industry has experienced exceptional growth during the past decade and is a global leader in life-sciences patents-per-capita. With offices in Jerusalem and Tel Aviv, Sha'ar Mivnim leverages strong relationships with Israel's renowned academic institutions and its unique network of relationships with key technology sources in the Israeli defense industry. The firm allocates over half of its investment capital to investments in Israeli companies or companies with significant R&D and operational ties to Israel, while the remainder is allocated to companies based in the U.S.

Investment Focus

• Exceptional technology or proprietary advantages
• Poised to capitalize on major market trends
• Early-stage life sciences companies
• Strong relationships with academic institutions
• Significant R&D and operational ties to Israel